echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Instruction of Pramipexole dihydrochloride

    The Instruction of Pramipexole dihydrochloride

    • Last Update: 2023-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pramipexole dihydrochloride is a pharmaceutical drug that is commonly used to treat Parkinson's disease and other movement disorders.
    It is a dopamine agonist, which means that it binds to dopamine receptors in the brain and mimics the effects of dopamine.
    This helps to improve the symptoms of Parkinson's disease, which are caused by a lack of dopamine in the brain.


    The production of pramipexole dihydrochloride involves several steps, including the synthesis of the active ingredient and the formulation of the final product.
    In this article, we will take a closer look at the instruction of pramipexole dihydrochloride in the chemical industry.


    Synthesis of Pramipexole Dihydrochloride
    The synthesis of pramipexole dihydrochloride involves several steps, including the preparation of the starting materials and the purification of the final product.
    The synthesis of pramipexole dihydrochloride typically involves the following steps:


    1. Preparation of the starting material: The starting material for the synthesis of pramipexole dihydrochloride is typically a compound called ephedrine, which is derived from the plant species Ephedra.
    2. Purification of the starting material: The ephedrine starting material is typically purified by chromatography, which involves separating the compound based on its physical and chemical properties.
    3. Synthesis of pramipexole: The next step in the synthesis of pramipexole dihydrochloride is the conversion of ephedrine into pramipexole.
      This is typically accomplished through a series of chemical reactions, which involve the formation of various intermediates.
    4. Purification of pramipexole: The pramipexole intermediate is typically purified by chromatography, which involves separating the compound based on its physical and chemical properties.
    5. Conversion of pramipexole into pramipexole dihydrochloride: The final step in the synthesis of pramipexole dihydrochloride is the conversion of pramipexole into its dihydrochloride salt form.
      This is typically accomplished through a process called hydrolysis, which involves the addition of hydrochloric acid to the pramipexole.

    Formulation of Pramipexole Dihydrochloride
    Once the synthesis of pramipexole dihydrochloride is complete, the next step is the formulation of the final product.
    This involves the combination of the pramipexole dihydrochloride powder with other ingredients to create a stable and effective pharmaceutical product.
    The formulation of pramipexole dihydrochloride typically involves the following steps:


    1. Milling: The pramipexole dihydrochloride powder is typically milled to reduce its particle size and improve its flowability.
    2. Mixing: The milled pramipexole dihydrochloride is then mixed with other ingredients, such as fillers, binders, and lubricants.
    3. Tableting: The mixture of pramipexole dihydrochloride and other ingredients is then compacted into tablets using a tableting machine.
    4. Coating: The tablets are then coated with a layer of polymer to protect the drug from degradation in the acidic environment of the stomach.

    Conclusion
    In summary, the production of pramipexole dihydrochloride involves the synthesis of the active ingredient and the formulation of the final product.
    The synthesis of pramipexole dihydrochloride typically involves the conversion of ephedrine into pramipexole, followed by the conversion of pramipexole into its dihydrochloride salt form.
    The formulation of pramipexole dihydrochloride typically involves the combination of the powder with other ingredients to create a stable and effective pharmaceutical product.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.